Chemotherapy resistance of glioblastoma stem cells

By A. Eramo, L. Ricci-Vitiani, A. Zeuner, R. Pallini, F. Lotti, G. Sette, E. Pilozzi, L. Larocca, C. Peschle, R. Maria. Cell Death and Differentiation, 2006

644 citations recorded by the source corpus.

Subfields: Genetics, Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/a306a58a86e68cd102cd735be1185336e756f5d2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. T. Schatton
2. M. Frank
3. N. Frank

Citations in the corpus

• Drug resistance and combating drug resistance in cancer (2019, background): “They have been reported to be involved in resistance to chemotherapeutic drugs in multiple cancer types, including leukemia[29], glioblastoma[30] and pancreatic cancer[31].”
• The therapeutic promise of the cancer stem cell concept. (2010, background): “For example, CSC chemoresistance has been reported in human leukemias (27, 80, 88–92), in malignant melanoma (13, 93), and in brain (94), breast (95, 96), pancreatic (37), and colorectal (97) cancers.”
• Identification and expansion of the tumorigenic lung cancer stem cell population (2008, result): “As we previously showed, these culture conditions allowed the selection of undifferentiated colon or glioblastoma cancer stem and progenitor cells, while serum-dependent differentiated tumor cells and non-transformed accessory cells were negatively selected.(14,22) Exposure of lung cancer cells to s”